BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18590700)

  • 1. Simultaneous assessment of the effects of exonic mutations on RNA splicing and protein functions.
    Ho PY; Huang MZ; Fwu VT; Lin SC; Hsiao KJ; Su TS
    Biochem Biophys Res Commun; 2008 Sep; 373(4):515-20. PubMed ID: 18590700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the mouse phenylalanine hydroxylase mutation Pah(enu3).
    Haefele MJ; White G; McDonald JD
    Mol Genet Metab; 2001 Jan; 72(1):27-30. PubMed ID: 11161825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
    Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
    Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function.
    Waters PJ; Parniak MA; Nowacki P; Scriver CR
    Hum Mutat; 1998; 11(1):4-17. PubMed ID: 9450897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive identification of exonic splicing enhancers in human genes.
    Fairbrother WG; Yeh RF; Sharp PA; Burge CB
    Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of phenylalanine hydroxylase deficiency in Southern Italy: a 96% detection rate with ten novel mutations.
    Daniele A; Cardillo G; Pennino C; Carbone MT; Scognamiglio D; Correra A; Pignero A; Castaldo G; Salvatore F
    Ann Hum Genet; 2007 Mar; 71(Pt 2):185-93. PubMed ID: 17096675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.
    Eng L; Coutinho G; Nahas S; Yeo G; Tanouye R; Babaei M; Dörk T; Burge C; Gatti RA
    Hum Mutat; 2004 Jan; 23(1):67-76. PubMed ID: 14695534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of arginine mutation for the evolutionary structure and function of phenylalanine hydroxylase gene.
    Lüleyap HU; Alptekin D; Pazarbaşi A; Kasap M; Kasap H; Demirhindi H; Mungan N; Ozer G; Froster UG
    Mutat Res; 2006 Oct; 601(1-2):39-45. PubMed ID: 16765994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations.
    Dianzani I; de Sanctis L; Smooker PM; Gough TJ; Alliaudi C; Brusco A; Spada M; Blau N; Dobos M; Zhang HP; Yang N; Ponzone A; Armarego WL; Cotton RG
    Hum Mutat; 1998; 12(4):267-73. PubMed ID: 9744478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.
    Waters PJ
    Hum Mutat; 2003 Apr; 21(4):357-69. PubMed ID: 12655545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation.
    Gjetting T; Petersen M; Guldberg P; Güttler F
    Mol Genet Metab; 2001 Feb; 72(2):132-43. PubMed ID: 11161839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
    Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro expression and structural analysis of four missense mutations (G247S, E280G, P362T, A434D) of phenylalanine hydroxylase gene].
    Song F; Qu Y; Okano Y; Ye Z; Zhang Y; Jin Y; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):1-5. PubMed ID: 18247293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mosaicism in a male with an exon skipping mutation in PDHA1 of the pyruvate dehydrogenase complex results in a milder phenotype.
    Okajima K; Warman ML; Byrne LC; Kerr DS
    Mol Genet Metab; 2006 Feb; 87(2):162-8. PubMed ID: 16412675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.